assay
≥97% (HPLC)
form
solid
color
pale yellow
solubility
ethanol: 1 mg/mL
DMSO: 50 mg/mL
General description
A cell-permeable naphthyridine-cyclohexyl Tpl2 Kinase Inhibitor (Cat. No. 616373) analog that acts as a potent ATP-competitive Tpl2 inhibitor (IC50 = 160 nM) with little activity (IC50 >20 μM) against EGFR, Src, MEK, p38, PKA, PKC, or S6. Reported to block LPS-induced TNF-α production both in vitro (IC50 = 0.5 and 4.5 μM using human monocytes and whole blood, respectively) and in rats in vivo (10 mg/kg, i.p.).
Preparation Note
Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
Storage Class
10-13 - German Storage Class 10 to 13
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Neelu Kaila et al.
Bioorganic & medicinal chemistry, 15(19), 6425-6442 (2007-08-01)
We have previously reported the discovery and initial SAR of the [1,7]naphthyridine-3-carbonitriles and quinoline-3-carbonitriles as Tumor Progression Loci-2 (Tpl2) kinase inhibitors. In this paper, we report new SAR efforts which have led to the identification of 4-alkylamino-[1,7]naphthyridine-3-carbonitriles. These compounds show
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service